Nikhil Uppal

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed

Herbert I. Hurwitz, Nikhil Uppal, Stephanie A. Wagner et al. · Journal of Clinical Oncology · 2015 · 287 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study

Bibek Khanal, Manjeshwar Shrinath Baliga, Nikhil Uppal · International Journal of Oral and Maxillofacial Surgery · 2010 · 123 citations

Pharmacy, Oral Health Sciences, Radiation Oncology +16

Venous thromboembolism in patients with diffuse large B-cell lymphoma

Rami S. Komrokji, Nikhil Uppal, Alok A. Khorana et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 85 citations

Medicine, Hematology, Oncology +17

A randomized double-blind phase 2 study of ruxolitinib (RUX) or placebo (PBO) with capecitabine (CAPE) as second-line therapy in patients (pts) with metastatic pancreatic cancer (mPC).

Herbert I. Hurwitz, Nikhil Uppal, Stephanie A. Wagner et al. · Journal of Clinical Oncology · 2014 · 51 citations

Medicine, Oncology, Pharmacology +15

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus <i>nab</i>-Paclitaxel and Gemcitabine in Advanced Solid Tumors

Gregory L. Beatty, Safi Shahda, Thaddeus Beck et al. · The Oncologist · 2018 · 47 citations · Full text

Medicine, Oncology, Pharmacology +16